In conclusion, our study revealed that B-Myb is overexpressed in CRC, and transactivates and interacts with E2F2 to promote human CRC cell proliferation, cell cycle progression, motility, at least in part, through activation of ERK and AKT pathways. This evidence concerns the gene E2F2 and colorectal carcinoma.